An analyst at Piper Jaffray has downgraded shares of Arena Pharma (Nasdaq: ARNA) this morning following yesterday's news that an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE